Hostname: page-component-89b8bd64d-72crv Total loading time: 0 Render date: 2026-05-07T10:03:04.912Z Has data issue: false hasContentIssue false

Hypothalamic dysfunction in obesity

Published online by Cambridge University Press:  06 September 2012

Lynda M. Williams*
Affiliation:
Metabolic Health Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Greenburn Road, Bucksburn, Aberdeen AB21 9SB, UK
*
Corresponding author: Lynda M. Williams, fax+44 1224 438 699, email: L.Williams@abdn.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

A growing number of studies have shown that a diet high in long chain SFA and/or obesity cause profound changes to the energy balance centres of the hypothalamus which results in the loss of central leptin and insulin sensitivity. Insensitivity to these important anorexigenic messengers of nutritional status perpetuates the development of both obesity and peripheral insulin insensitivity. A high-fat diet induces changes in the hypothalamus that include an increase in markers of oxidative stress, inflammation, endoplasmic reticulum (ER) stress, autophagy defect and changes in the rate of apoptosis and neuronal regeneration. In addition, a number of mechanisms have recently come to light that are important in the hypothalamic control of energy balance, which could play a role in perpetuating the effect of a high-fat diet on hypothalamic dysfunction. These include: reactive oxygen species as an important second messenger, lipid metabolism, autophagy and neuronal and synaptic plasticity. The importance of nutritional activation of the Toll-like receptor 4 and the inhibitor of NF-κB kinase subunit β/NK-κB and c-Jun amino-terminal kinase 1 inflammatory pathways in linking a high-fat diet to obesity and insulin insensitivity via the hypothalamus is now widely recognised. All of the hypothalamic changes induced by a high-fat diet appear to be causally linked and inhibitors of inflammation, ER stress and autophagy defect can prevent or reverse the development of obesity pointing to potential drug targets in the prevention of obesity and metabolic dysfunction.

Information

Type
70th Anniversary Conference on ‘Body weight regulation – food, gut and brain signalling’
Copyright
Copyright © The Author 2012
Figure 0

Fig. 1. (colour online) The major intracellular pathways involved in the induction of hypothalamic dysfunction are illustrated. All of these pathways interact with one another to amplify the response to a high-fat diet and obesity. Interactions between pathways are shown in both solid and dotted lines. Key: peroxisomes are shown in green and mitochondria in orange. ER, endoplasmic reticulium; IKKβ, inhibitor of nuclear factor κB kinase subunit β; JNK, c-Jun amino-terminal kinase; LCSFA, long-chain SFA; TLR4, Toll-like receptor 4; TNFR1, tumour necrosis factor receptor 1.

Figure 1

Fig. 2. (colour online) The major neuronal cell types that control energy balance are part of the melanocortin system in the hypothalamus. They are mostly located in the arcuate and ventromedial nuclei. They are referred to as first-order neurons as they receive direct input from circulating hormones such as leptin, insulin and ghrelin. They then signal second-order neurons in areas such as the paraventricular nuclei. 3 V, third ventricle; AgRP, agouti-related peptide; αMSH, α melanocyte-stimulating hormone; CART, cocaine and amphetamine-regulated transcript; MC4R, melanocortin receptor 4; NPY, neuropeptide Y; POMC, proopiomelanocortin.

Figure 2

Fig. 3. (colour online) Synaptic plasticity is important in the maintenance of energy balance in addition to direct input from peripheral hormones such as leptin, insulin and ghrelin. This figure illustrates how the two major energy balance neuronal types in the hypothalamus interact with one another via synaptic inputs which are largely inhibitory. AgRP, agouti-related peptide; CART, cocaine and amphetamine-regulated transcript; GABA, γ-aminobutyric acid; NPY, neuropeptide Y; POMC, proopiomelanocortin.